Reduced-intensity chemo and radiation before a donor bone marrow transplant
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests a lower-intensity chemotherapy and radiation plan before getting a bone marrow (stem cell) transplant from a related donor. It’s meant for people with blood cancers who are considered at higher risk of relapse with standard lower-intensity treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a related donor matched well enough (3 out of 6 to 5 out of 6 matches) and the donor test does not show an incompatible response in the transplant direction
- You can have your performance/strength level assessed and score 70% or higher
- You have a blood cancer where your doctors expect a high risk of relapse with less intense (non-myeloablative) treatment before transplant
- Your heart pumping function is strong enough (LVEF 45% or higher)
- Your lungs work well enough (FEV, FVC, and lung DLCO are all 60% or higher)
- Your liver and kidneys function are strong enough (bilirubin below 2.5, AST/ALT not more than 3 times normal, and kidney filtration 40 mL/min or higher)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a stem cell transplant using milder chemotherapy (treosulfan and fludarabine) followed by a drug called cyclophosphamide to prevent graft-versus-host disease. It aims to make transplant safer for people with blood diseases who cannot handle standard high-dose chemotherapy.
This trial tests a less intense type of bone marrow (stem cell) transplant from a partly matched family donor for people with high-risk solid tumors. It aims to lower treatment intensity while still using the donor’s immune system to help control the cancer.
This trial tests a less intense chemotherapy regimen to prepare patients with MDS for a stem cell transplant. It may be an option if you have intermediate or high-risk MDS and are between 14 and 70 years old.
This trial tests a stronger chemotherapy and radiation regimen before a donor stem cell transplant for people with acute myeloid leukemia or high-risk myelodysplastic syndrome. The goal is to eliminate any remaining cancer cells and improve transplant success.
This trial tests a risk-adapted conditioning regimen (chemotherapy and/or radiation given before transplant) for people with certain blood cancers or bone marrow disorders who need a stem cell transplant from a donor. The goal is to tailor the conditioning strength to each patient’s risk, which may help improve outcomes and reduce side effects.
This trial tests a special bone marrow/stem cell transplant approach using a partially matched family donor, along with conditioning treatment that involves radiation. It aims to help treat certain blood cancers by replacing damaged blood-forming cells with new ones from the donor.
Hear when a new Hematologic Malignancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.